You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / NATCO PHARMA LTD

NATCO PHARMA LTD Analysis

Returns | 1W : -1.7% , 1M : -4%,1Y : 39.5%
BOM : 524816     NSE : NATCOPHARM    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward
Pledged Shares : None or < 25%
Jan 25,2021
Price(EOD): Rs. 894.05
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
MarketCap: Rs. 16,289.59 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
NATCO PHARMA LTD -1.7% -4% 39.5%
SUN PHARMACEUTICAL INDUSTRIES LTD -1.6% -0.6% 27.8%
DR REDDYS LABORATORIES LTD -0.1% -2.3% 65.7%
DIVIS LABORATORIES LTD -0.9% -4.8% 86.8%
CIPLA LTD 1.8% 0.4% 73.9%
BIOCON LTD -15.3% -20.6% 33.9%
AUROBINDO PHARMA LTD 8% 9.8% 88.7%
LUPIN LTD -0.8% 10.8% 46.3%
TORRENT PHARMACEUTICALS LTD -4.2% -5.3% 33.1%

FUNDAMENTAL ANALYSIS OF NATCO PHARMA LTD

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than NATCO PHARMA LTDPremium

As on 25-Jan-2021, the Fundamentals of NATCO PHARMA LTD are Strong and hence it's good for long term investment! See Financial Performance of NATCO PHARMA LTD. Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF NATCO PHARMA LTD

 
Valuation Score
RatioValue
P/E
P/B
P/S
34.29
P/E Calculated based on EPS of 26.07
[ Mar2020 - Standalone Results ]

4.23
P/B Calculated based on Book Value of 211.31
[ Mar2020 - Standalone Results ]

8.77
P/S Calculated based on Revenues of 1857.7 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than NATCO PHARMA LTDPremium

As on 25-Jan-2021, NATCO PHARMA LTD is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!


INTRINSIC VALUE OF NATCO PHARMA LTD

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
106%
30%
32%

As on 25-Jan-2021, the Intrinsic Value of NATCO PHARMA LTD is Rs. 678.03 determined based on Median of the 3 historical models.
Fair Value based on Median EV / EBIDTA Model : Rs. 434.76
Fair Value based on Median EV / Sales Model : Rs. 686.43
Fair Value based on Median Price / Sales Model : Rs. 678.03
Median Fair Value of NATCO PHARMA LTD : Rs. 678.03

As on 25-Jan-2021, NATCO PHARMA LTD is trading at a Premium of 32% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF NATCO PHARMA LTD

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.08
0.11
0.06
0.08
0.08
0.11
0.06
0.08
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
-10.02%
-38.91%
-46.47%
-44.04%
4.63%
-31.19%
-39.76%
-41.98%
QtrlyTrend
-6
Latest Qtr: Sep2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z